Rabson–Mendenhall syndrome
Rabson–Mendenhall syndrome is a rare genetic disorder characterized by severe insulin resistance. It is part of a group of conditions known as insulin receptor disorders, which also includes Donohue syndrome and type A insulin resistance syndrome. The syndrome is named after Dr. S. M. Rabson and Dr. L. S. Mendenhall, who first described the condition.
Clinical Features[edit | edit source]
Individuals with Rabson–Mendenhall syndrome typically present with a range of symptoms that may include:
- Severe insulin resistance
- Hyperglycemia
- Acanthosis nigricans
- Dysplastic teeth
- Hirsutism
- Pineal hyperplasia
- Growth retardation
Genetics[edit | edit source]
Rabson–Mendenhall syndrome is caused by mutations in the INSR gene, which encodes the insulin receptor. This gene is located on chromosome 19. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
Diagnosis[edit | edit source]
Diagnosis of Rabson–Mendenhall syndrome is based on clinical features and confirmed by genetic testing. Laboratory tests typically show elevated levels of insulin and glucose in the blood, indicating severe insulin resistance.
Treatment[edit | edit source]
There is no cure for Rabson–Mendenhall syndrome, and treatment is primarily supportive. Management strategies may include:
- High doses of insulin
- Dietary modifications
- Metformin and other insulin-sensitizing agents
- Monitoring and treatment of complications such as diabetes mellitus and hyperglycemia
Prognosis[edit | edit source]
The prognosis for individuals with Rabson–Mendenhall syndrome varies. The condition is often severe and can lead to significant health complications. Early diagnosis and management are crucial for improving outcomes.
See Also[edit | edit source]
- Insulin receptor disorders
- Donohue syndrome
- Type A insulin resistance syndrome
- Hyperglycemia
- Acanthosis nigricans
References[edit | edit source]
External Links[edit | edit source]
-
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD